Kenneth K W To
Overview
Explore the profile of Kenneth K W To including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1685
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu X, To K, Zeng Q, Fu L
Adv Sci (Weinh)
. 2025 Feb;
:e2417357.
PMID: 39899680
The crosstalk between immunity and cancer in the regulation of tumor growth is considered a hallmark of cancer. Antitumor immunity refers to the innate and adaptive immune responses that regulate...
2.
Mai Z, Fu L, Su J, To K, Yang C, Xia C
Mol Cancer
. 2025 Jan;
24(1):33.
PMID: 39871258
No abstract available.
3.
Mai Z, Fu L, Su J, To K, Yang C, Xia C
Mol Cancer
. 2025 Jan;
24(1):6.
PMID: 39780177
Background: Intratumor-resident bacteria represent an integral component of the tumor microenvironment (TME). Microbial dysbiosis, which refers to an imbalance in the bacterial composition and bacterial metabolic activities, plays an important...
4.
Zhang H, To K
Clin Transl Sci
. 2024 Oct;
17(11):e70053.
PMID: 39473122
Molecular targeted tyrosine kinase inhibitors (TKIs) have produced unprecedented treatment response in cancer therapy for patients harboring specific oncogenic mutations. While the TKIs are mostly well tolerated, they were reported...
5.
To K, Zhang H, Cho W
Cancer Drug Resist
. 2024 Oct;
7:37.
PMID: 39403602
Competing endogenous RNAs (ceRNAs) are transcripts that possess highly similar microRNA response elements (MREs). microRNAs (miRNAs) are short, endogenous, single-stranded non-coding RNAs (ncRNAs) that can repress gene expression by binding...
6.
Yang K, Fu K, Zhang H, Wang X, To K, Yang C, et al.
Mol Cancer
. 2024 Sep;
23(1):209.
PMID: 39342174
Background: BCR-ABL is a constitutively active tyrosine kinase that stimulates multiple downstream signaling pathways to promote the survival and proliferation of chronic myeloid leukemia (CML) cells. The clinical application of...
7.
Zhang P, Zeng P, Lai C, Ip M, To K, Zuo Z, et al.
Int J Biol Macromol
. 2024 Aug;
278(Pt 2):134670.
PMID: 39151868
Endolysins (lysins), a novel class of antibacterial agents derived from bacteriophages, efficiently lyse bacteria by degrading the peptidoglycan layer within the bacterial wall. Colistin, a classic peptide antibiotic with the...
8.
Said N, Mahmood S, To K
Front Pharmacol
. 2024 May;
15:1403176.
PMID: 38766630
No abstract available.
9.
Yang C, Wang X, To K, Cui C, Luo M, Wu S, et al.
Signal Transduct Target Ther
. 2024 Apr;
9(1):84.
PMID: 38575583
Circulating tumor cells (CTCs) are precursors of distant metastasis in a subset of cancer patients. A better understanding of CTCs heterogeneity and how these CTCs survive during hematogenous dissemination could...
10.
To K, Huang Z, Zhang H, Ashby Jr C, Fu L
Drug Resist Updat
. 2024 Jan;
73:101058.
PMID: 38277757
Multidrug resistance (MDR) is one of the primary factors that produces treatment failure in patients receiving cancer chemotherapy. MDR is a complex multifactorial phenomenon, characterized by a decrease or abrogation...